PHASQ Stock Forecast - PhaseBio Pharmaceuticals Inc

	PhaseBio Pharmaceuticals Inc OTC:PHASQ	US
V	Versant Media Group Inc NASDAQ:VSNT	US
P	Phol Dhanya PCL SET:PHOL	TH
C	Christian Dior SE OTC:CHDRY	FR
S	SEI Medical PCL SET:SEI	TH
	Wheels Up Experience Inc NYSE:UP	US
M	Moda InnoChips Co Ltd KOSDAQ:080420	KR
	Falco Resources Ltd XTSX:FPC	CA
B	BG Container Glass PCL SET:BGC	TH
	Caltagirone Editore SpA MIL:CED	IT
	Asiamet Resources Ltd LSE:ARS	CA
	Crew Energy Inc TSX:CR	CA
N	NNIT A/S CSE:NNIT	DK
G	Groupe Tera SA PAR:ALGTR	FR
	111 Inc NASDAQ:YI	CN
	Oxford Biodynamics PLC LSE:OBD	UK
	Pluri Inc NASDAQ:PLUR	IL
	Companhia Energetica do Rio Grande do Norte Cosern BOVESPA:CSRN3	BR
	Theraclion SA PAR:ALTHE	FR
	Century Therapeutics Inc NASDAQ:IPSC	US
O	Osotspa PCL SET:OSP	TH
E	Eason & Co PCL SET:EASON	TH
	Advanced Emissions Solutions Inc NASDAQ:ARQ	US
	Cardinal Energy Ltd (Alberta) TSX:CJ	CA

Wall St Price Targets

There are no price targets for PHASQ.

PHASQ Lowest Forecast

PHASQ Average Forecast

PHASQ Highest Forecast

UFP Technologies Inc

9% Upside

Nephrocare Health Services Ltd

14% Upside

UFP Technologies Inc

9% Upside

Nephrocare Health Services Ltd

14% Upside

Revenue
Forecast

3 285% / Year

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

3 285% / Year

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

Over the last 1 year, the compound annual growth rate for Revenue has been 3 285%.

What are analyst estimates?

Gross Profit
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

What are analyst estimates?

Net Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

What are analyst estimates?

Continue PHASQ Research

Summary

DCF Valuation

Relative Valuation

Wall St Estimates

Profitability

Solvency

Financials

Discount Rate

F • EUR

2K4

NASDAQ • USD

PHAS

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

PHASQ does not have any price targets made by Wall Street professionals.

Back to Top

PhaseBio Pharmaceuticals Inc
OTC:PHASQ

Wall St Price Targets

PHASQ Price Targets Summary
PhaseBio Pharmaceuticals Inc

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

Continue PHASQ Research

What is PHASQ's stock price target?

Not Available

Company

Help

Tools

Stocks

PhaseBio Pharmaceuticals Inc OTC:PHASQ

Wall St Price Targets

PHASQ Price Targets Summary PhaseBio Pharmaceuticals Inc

Revenue Forecast

Gross Profit Forecast

Operating Income Forecast

Pre-Tax Income Forecast

Net Income Forecast

Continue PHASQ Research

What is PHASQ's stock price target? Not Available

Company

Help

Tools

Stocks

PhaseBio Pharmaceuticals Inc
OTC:PHASQ

PHASQ Price Targets Summary
PhaseBio Pharmaceuticals Inc

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

What is PHASQ's stock price target?

Not Available